Vimarsana
Biggest News Aggregation in the World

Page 30 - Evelop News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evelop. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evelop Today - Breaking & Trending Today

OMV Petrom, Romgaz to Invest Up to $4.4 Billion to Develop Romania Gas Project - Vimarsana News

OMV Petrom, Romgaz to Invest Up to $4.4 Billion to Develop Romania Gas Project

By Adria Calatayud OMV said Wednesday that its 51%-owned OMV Petrom and Romgaz will jointly invest up to 4 billion euros to develop an offshore natural-gas project in Romania. The... | June 21, 2023

Oxford Research Fellow recognised by Forbes - Vimarsana News

Oxford Research Fellow recognised by Forbes

Oxford University Senior Research Fellow, Robert House, who is working on the next generation of rechargeable battery materials at Diamond Light Source, has been selected as one of Forbes Magazine’s prestigious 30 people to watch under 30 in Europe Science and Healthcare. Click to read more...

Fortum Oyj : first solar power project in Finland being planned in Virolahti - Vimarsana News

Fortum Oyj : first solar power project in Finland being planned in Virolahti

Fortum and the municipality of Virolahti are starting to develop an 80-megawatt industrial-scale solar power project in the Yläpää and Uusitalo areas in Virolahti. The project... | June 20, 2023

C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer - Vimarsana News

C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer

WATERTOWN, Mass., June 20, 2023 -- C4 Therapeutics, Inc. , a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of... | June 20, 2023

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 20, 2023 /PRNewswire/ -- Cardiff Oncology, Inc. , a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies... | June 20, 2023